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Monofunctional alkylating agents like methyl methanesulfonate (MMS) and N-methyl-N*-nitro-N-nitroso-
guanidine (MNNG) are potent inducers of cellular stress leading to chromosomal aberrations, point muta-
tions, and cell killing. We show that these agents induce a specific cellular stress response program which
includes the activation of Jun N-terminal kinases/stress-activated protein kinases (JNK/SAPKs), p38 mitogen-
activated protein kinase, and the upstream kinase SEK1/MKK4 and which depends on the reaction mechanism
of the alkylating agent in question. Similar to another inducer of cellular stress, UV irradiation, damage of
nuclear DNA by alkylation is not involved in the MMS-induced response. However, in contrast to UV and other
inducers of the JNK/SAPKs and p38 pathways, activation of growth factor and G-protein-coupled receptors
does not play a role in the MMS response. We identified the intracellular glutathione (GSH) level as critical
for JNK/SAPK activation by MMS: enhancing the GSH level by pretreatment of the cells with GSH or N-
acetylcysteine inhibits, whereas depletion of the cellular GSH pool causes hyperinduction of JNK/SAPK activ-
ity by MMS. In light of the JNK/SAPK-dependent induction of c-jun and c-fos transcription, and the Jun/Fos-
induced transcription of xenobiotic-metabolizing enzymes, these data provide a potential critical role of
JNK/SAPK and p38 in the induction of a cellular defense program against cytotoxic xenobiotics such as MMS.
Monofunctional alkylating agents are versatile environmen-
tal mutagens and carcinogens (61). Once formed or activated,
they induce diverse aspects of severe cellular stress, including
chromosomal aberrations, sister chromatid exchanges, point
mutations, and cell killing. The agents react with a variety of
nucleophilic sites in DNA and protein, generating various
types of adducts (70). The relative amount of alkyl adducts
varies with the type of agent; it is largely determined by its
electrophilicity (71).
DNA-damaging agents as well as other agents causing cel-
lular stress, such as UV irradiation, heat shock, or protein
synthesis inhibitors, cause a specific cellular stress response.
This program includes the transcriptional induction of the
proto-oncogene c-jun. c-Jun is a member of a multiprotein
family that has been implicated in a number of signal trans-
duction pathways associated with cellular growth, differentia-
tion, neuronal excitation, and cellular stress (2, 3, 24, 25, 34, 37,
56, 75) and is thought to be required for cellular defense
against toxicity (68). Induction of c-jun in response to geno-
toxic agents and cellular stress is mediated by two AP-1-like
sites in its promoter that are recognized by either c-Jun homo-
dimers (4, 20), ATF-2 homodimers, or, preferentially, c-Jun–
ATF-2 heterodimers (77, 78). The activity of these complexes
is stimulated by hyperphosphorylation of the transactivation
domain of promoter-associated c-Jun and ATF-2 (31, 46, 62,
73, 74, 78). Both proteins are efficiently phosphorylated by a
single type of protein kinase termed JNK (Jun N-terminal
protein kinase), also known as SAPK (stress-activated protein
kinase), which exists in several isoforms (22, 32, 33, 42) that are
members of the mitogen-activated protein kinase (MAPK)
group of protein kinases (19). Similar to activation of the
MAPKs extracellular signal-regulated kinases 1 and 2 (ERK-1
and ERK-2), which are activated predominantly by growth
factors and the phorbol ester 12-O-tetradecanoylphorbol-13-
acetate, JNK activation requires phosphorylation at two resi-
dues, Thr-183 and Tyr-185, by JNK kinase, also termed SEK1/
MAPK kinase 4 (MKK4) (23, 44, 67), a dual-specificity kinase
which is structurally related to MAPK/ERK kinases (MEKs).
MKK4 is activated by phosphorylation mediated by one of
several upstream protein kinases, for example, MEK kinase 1
(MEKK1) (51, 82). Additional upstream kinases involved in
this protein kinase cascade are PAK protein kinases, which are
activated by the small GTP binding proteins Rac1 and Cdc42
(6, 16, 17, 52, 59) and possibly Pyk2 (76).
While these kinase cascades induced by tumor necrosis fac-
tor alpha (TNF-a) or UV have been analyzed extensively,
neither the upstream kinases induced by alkylating agents lead-
ing to the activation of JNK/SAPKs nor the primary sensors of
the cell that trigger the stress response have been identified.
Here we show that monofunctional alkylating agents, such as
methyl methanesulfonate (MMS) and N-methyl-N9-nitro-N-
nitrosoguanidine (MNNG), whose biological activities are
characterized by efficient induction of chromosomal aberra-
tions, sister chromatid exchanges, and cell killing, are very
potent inducers of two subclasses of MAPKs, p46/54 JNK/
SAPKs and p38, but, in contrast to UV, affect neither ERK-1
nor ERK-2. Interestingly, ethylnitrosourea (ENU), the most
potent alkylating agent to induce mutagenesis and carcinogen-
esis, failed to induce either one of these kinases. Efficient
induction of JNK/SAPKs was also observed in enucleated cells,
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demonstrating that damage of genomic DNA is not required to
trigger the MMS response. MMS-induced signalling includes
SEK1/MKK4 and possibly MEKK1. Despite the fact that
MMS and UV share the ability to induce p38- and JNK/SAPK-
dependent signalling pathways regulating expression of c-Jun–
ATF-2-dependent target genes, such as c-jun, activation of
growth factor receptors required for the UV response is not
involved in the initiation of MMS-dependent signal transduc-
tion pathways. We identified the redox state of the cell as
critical for JNK/SAPK and p38 activation by MMS: while in-
duction of JNK/SAPKs and p38 was almost completely blocked
by pretreatment of the cells with reducing agents, such as
glutathione (GSH) and N-acetylcysteine (NAC), depletion of
the intracellular pool of GSH resulted in superinduction of
JNK/SAPK activity by MMS. In light of the AP-1-dependent
induction of GSH synthesis in response to alkylating agents,
these data suggest a potential critical role of JNK/SAPKs and
p38 activation in the regulation of the cellular defense program
against the harmful consequences of MMS-induced cellular
toxicity.
MATERIALS AND METHODS
Chemicals. Stock solutions of MMS and MNNG (obtained from Serva, Heidel-
berg, Germany) were prepared as described by Kaina et al. (38). L-Buthionine-
S,R-sulfoximine (BSO), human epidermal growth factor (EGF), NAC, and TNF-
a were purchased from Sigma Chemical Co.; GSH was purchased from Fluka.
Stock solutions of suramin (Germanin; Bayer Leverkusen) and ENU (33
recrystallized; kindly provided by Manfred Rajewsky) were freshly prepared in
phosphate-buffered saline and diluted into the cell culture to final concentrations
of 0.3 mM and 1 mM, respectively.
Cell culture and treatment of cells. HeLa, Jurkat, 293, NIH 3T3, and mouse
L cells were grown at 37°C and 6% CO2 in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum. Transient transfection of cells was
performed as described previously (78).
For UV irradiation of cells, the culture medium was removed and UVC
irradiated (40 J/m2) where indicated, and the original culture medium was added
back to the cells. Chemicals were added in the culture medium from concen-
trated stock solutions.
Enucleation of cells was performed as described previously (11). Briefly, 106
cells were seeded into a 25-cm2 tissue culture flask 24 h prior to enucleation. For
enucleation, the culture flask was filled with prewarmed medium (37°C) and
cytochalasin B was added to a final concentration of 10 mg/ml. Flasks were
immediately placed into the prewarmed (37°C) bottle cavities (GSA rotor of a
Sorvall R2C centrifuge), and cells were spun down at 8,500 rpm for 30 min. After
centrifugation, the karyoplast pellet was removed, and the cytoplasts were
washed once with culture medium and then placed in regular culture medium to
allow recovery for 14 to 16 h prior to induction. To test the efficiency of enu-
cleation, the cells and cytoplasts were stained with the fluorescent DNA dye
Hoechst 33528.
Protein kinase assays. In-gel kinase assay was performed as described previ-
ously (78). The activation of MAPKs (ERK-1 and -2) was determined either by
Western blot analysis as described by Radler-Pohl et al. (64) or by an immune
complex kinase assay using myelin basic protein as a substrate. Phospho-p38 was
detected by Western blot analysis using a phospho-p38-specific polyclonal anti-
body (New England Biolabs) according to the manufacturer’s instructions. For
the immune complex kinase assay, cells were left untreated or stimulated with
various agents. Subsequently, cells were washed twice with ice-cold phosphate-
buffered saline and lysed at 0°C in lysis buffer (20 mM Tris [pH 7.5], 137 mM
NaCl, 2 mM EDTA, 1% Triton X-100, 10% glycerol, 25 mM b-glycerophos-
phate, 2 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM phenyl-
methylsulfonyl fluoride, 10 mg of aprotinin per ml, 10 mg of leupeptin per ml, and
10 mg of pepstatin per ml). The lysate was centrifuged (13,000 rpm, 0°C for 20
min), and 1.5 ml of polyclonal antibodies raised against JNK1 (C-17; Santa Cruz
Biotechnology) and JNK2 (FL; Santa Cruz), 2 ml of polyclonal antibody raised
against ERK-1 (K-23; Santa Cruz), 1.5 ml polyclonal antiserum raised against the
Flag epitope (D-8; Santa Cruz), or 1 mg monoclonal antibody against the hem-
agglutinin (HA) epitope (Boehringer Mannheim) was added to the supernatant,
together with 50 ml of a 50% suspension of protein A-Sepharose beads. After 2 h
of incubation at 4°C, the beads were washed twice with lysis buffer and once with
kinase buffer. The immune complex kinase assays were performed in 25 ml of
kinase buffer, consisting of 25 mM HEPES (pH 7.4), 25 mM MgCl2, 25 mM
b-glycerophosphate, 1 mM dithiothreitol, 0.1 mM sodium orthovanadate, and 5
mCi of [g-32P]ATP containing 2 mg of either glutathione S-transferase (GST)–
Jun 1/166, GST-SAPK, or myelin basic protein. After 20 min at 30°C, sample
buffer was added, proteins were separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE), and phosphorylated substrates were
visualized by autoradiography.
RESULTS
Induction of JNK/SAPKs by specific classes of alkylating
agents. A number of transcription factors such as c-Jun, c-Fos,
and p62 TCF/Elk-1 have been shown to be phosphorylated in
vitro and in vivo by distinct members of the MAPK family (21,
22, 28–30, 42, 62, 63, 81, 84) triggered by a large variety of
extracellular conditions, in particular by agents that induce
cellular stress. We have shown previously that one group of the
MAPK family, the JNK/SAPKs, are activated in response to
the alkylating agent MMS in many cell lines, e.g., HeLa cells,
Jurkat cells, immortalized mouse fibroblasts, and 293 cells (ref-
erence 78, Fig. 1, and data not shown), in a dose-dependent
manner (Fig. 1). Alkylating agents react with a variety of nu-
cleophilic sites in DNA and protein, leading to different types
of adducts. MMS and MNNG are known to react almost ex-
clusively with the ring nitrogens of the purine bases, particu-
larly N-7 of guanine (7), which correlates with the induction of
cell killing, chromosomal aberrations, and sister chromatid ex-
changes (58). Only about 0.3% of the total alkyl adducts in
DNA are O6-methylguanine, which is the lesion critical in
mutagenesis and malignant transformation. In contrast, ENU,
which produces about 9% O6-ethylguanine, is the most potent
alkylating agent with respect to mutagenicity and carcinoge-
nicity. The relative frequency of the different types of adducts
depends in particular on the electrophilicity and therefore on
the chemical reaction pattern of the alkylating agent in ques-
tion.
To determine whether the activation of JNK/SAPKs is a
general response to alkylating agents, both MNNG and ENU,
representing either one of the two classes of monofunctional
alkylating agents, were tested by immune complex kinase as-
says. MMS induced a transient activation of JNK/SAPK activ-
ity peaking 2 h after stimulation (Fig. 2A). Similarly, MNNG
was a very potent inducer of JNK/SAPK activity (Fig. 2B).
In-gel kinase assays confirmed that both p54 and p46 JNK/
SAPK isoforms are activated upon MMS or MNNG treatment
(data not shown).
In contrast, ENU at a concentration (1 mM) which is mu-
tagenic in cultured mammalian cells (for a review, see refer-
ence 69), did not affect JNK/SAPK activity as measured by
immune complex kinase assay (data not shown). Even a 10-fold
higher concentration of ENU (10 mM), which led to efficient
cell killing within 3 h, did not induce, and even slightly reduced,
JNK/SAPK activity (Fig. 2C). In line with the lack of JNK/
SAPK activation, we did not observe transcriptional activation
of the c-jun gene upon ENU treatment (data not shown).
These results demonstrate that the activation of the stress
response in the cells depends on the type of alkylating agent.
Only substances like MMS and MNNG, which react preferen-
tially with receptor atoms with high nucleophilic strength, are
FIG. 1. Dose-dependent activation of JNK/SAPKs. Human 293 cells were
left untreated (Co) or treated with the indicated concentrations of MMS. The
cells were harvested 2 h after stimulation, and whole-cell extracts were prepared.
Activation of JNK/SAPKs was determined by an immune complex kinase assay
using GST-Jun 1/166 as the substrate.
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potent activators of the JNK/SAPK signal transduction path-
way. In contrast, ENU, which reacts with low-nucleophilic-
strength sites, failed to do so.
Protein kinase cascades induced by MMS. To determine
whether the activation of MAPKs by MMS is restricted to the
JNK/SAPK subfamily, we measured the activities of the two
other members of the MAPK family, ERKs (p44 ERK-1 and
p42 ERK-2), and p38, in response to MMS treatment. JNK/
SAPKs, ERKs, and p38 represent the three subfamilies, which
are characterized by distinct dual phosphorylation motifs (23,
57) and which differ in their substrate specificities. ERKs are
activated predominantly by growth factors or phorbol esters
(reviewed in reference 48); SAPKs (JNKs) and p38 kinase are
both activated by inflammatory cytokines and cellular stress,
such as heat and osmotic shock, or UV irradiation (27, 42, 65).
To determine the activation of ERK-1 and ERK-2, we per-
formed Western blot analysis using antibodies that recognize
both ERK-1 and -2, exploiting the mobility shift of these ki-
nases, which is indicative of their phosphorylation and activa-
tion status (43). Both ERK-1 and ERK-2 were activated within
15 min after EGF treatment, whereas no mobility shift was
observed after MMS treatment up to 4 h (Fig. 3A). Induction
of ERK-1 and ERK-2 activity by EGF (2.9-fold), but not MMS,
was confirmed by an immune complex kinase assay using my-
elin basic protein as a substrate (Fig. 3B).
Similar to ERK-1 and ERK-2, p38 MAPK is activated by
phosphorylation of Thr and Tyr residues, which can be moni-
tored by Western blot analysis using an antiserum specific for
phospho-p38. As shown in Fig. 3C, MMS treatment leads to
enhanced phosphorylation of p38, reaching maximal levels 2 h
poststimulation. To measure directly p38 MAPK activity, an
expression vector encoding an epitope-tagged p38 protein was
transiently transfected into 293 cells, and cells were treated
with MMS or UV (40 J/m2). Exogenously expressed p38 was
purified by immunoprecipitation, and p38 activity was deter-
mined by an immune complex kinase assay using an antibody
against the Flag epitope and bacterially expressed GST–ATF-2
as the substrate. Similar to the activation by UV irradiation,
treatment of the cells with MMS led to the activation of Flag-
p38. The kinetics of induction of p38 and JNK/SAPKs were
very similar, reaching maximal levels 2 h poststimulation (Fig.
3D and data not shown). These data demonstrate that both
JNK/SAPKs and p38 MAPK, but not ERK-1 and -2, are com-
ponents of signal transduction pathways initiated by the alky-
lating agent MMS.
In general, signal transduction pathways represent cascades
of protein kinases which are subsequently activated after the
initiating primary signal. For example, JNK/SAPKs can be ac-
tivated by phosphorylation at two residues, Thr-183 and Tyr-185,
by MKK4, also termed SEK1 or JNKK. MKK4/SEK1 is able to
activate both JNK/SAPKs and p38 MAPK (23). It is closely
related to MKK3, a specific activator of p38 MAPK. MKK3
activity is enhanced by UV irradiation, inflammatory cytokines,
and osmotic shock (23). MKK4/SEK1 itself is phosphorylated
and activated by upstream kinases, such as MEKK1. The mech-
anism of MEKK1 activation is still unclear.
To examine whether MMS-induced signalling also includes
these known members of the JNK/SAPK kinase cascade, we
FIG. 2. Activation of JNK/SAPK by different types of alkylating agents. (A)
Human 293 cells were left untreated (Co) or treated with MMS (1 mM). The
cells were harvested at the indicated time points after stimulation, and whole-cell
extracts were prepared. Activation of JNK/SAPKs was determined by an immune
complex kinase assay using GST-Jun 1/166 as the substrate (B). Whole-cell
extracts from untreated 293 cells (Co) or cells treated with MNNG (70 mM) for
the indicated times were analyzed by an immune complex kinase assay as de-
scribed for panel A (C). Human 293 cells were left untreated or treated with
ENU (10 mM) for the indicated times, or MMS (1 mM) for 2 h, and whole-cell
extracts were prepared. Activation of JNK/SAPKs was determined by an immune
complex kinase assay with GST-Jun 1/166 as the substrate. The products of the
phosphorylation reaction were resolved by SDS-PAGE and detected by autora-
diography.
FIG. 3. Activation of p38 MAPK, but not ERK-1 and -2, by MMS. (A) Cell
lysates were prepared from 293 cells at the indicated time points after MMS (1
mM) or EGF (10 ng/ml) treatment. Co, extract from untreated cells. Thirty
micrograms of total cell lysate was resolved by SDS-PAGE (10% gel), and the
ratio of activated and nonactivated forms of p42 and p44 MAPKs was measured
by Western blot analysis using p42/44MAPK-specific polyclonal rabbit antibodies
(66). Activation of the kinases is measured by the appearance of the slower-
migrating forms of p42 and p44 MAPKs. The lower panel is a five-times-longer
exposure of the upper panel to visualize activation of p44 MAPK. (B) Activation
of ERK-1 and ERK-2 was determined by an immune complex kinase assay using
myelin basic protein (MBP) as the substrate. (C) Thirty micrograms of total cell
lysate was resolved by SDS-PAGE (10% gel), and the amount of phospho-p38
was detected by Western blot analysis using phospho-p38-specific polyclonal
rabbit antibodies. Cells were left untreated (Co), irradiated with UV (40 J/m2)
and harvested after 30 min, or treated with MMS (1 mM) for the indicated times.
(D) Human 293 cells transiently transfected with an epitope-tagged p38 MAPK
expression vector were left untreated (Co), irradiated with UV (40 J/m2), or
treated with MMS (1 mM) for the indicated times. The p38 MAPK was immu-
noprecipitated with Flag-probe rabbit polyclonal antibody D-8 (Santa Cruz).
Immune complex kinase assays were performed with GST–ATF-2 as the sub-
strate. The products of the phosphorylation reaction were resolved by SDS-
PAGE and detected by autoradiography.
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first studied the effect of MMS on the activation status of
SEK1. An expression vector encoding an HA-tagged SEK1
protein was transfected into 293 cells. Extracts from untreated
and MMS-treated cells were prepared, and expression of equal
amounts of HA-SEK in untreated and MMS-treated cells was
confirmed by Western blot analysis using an HA-specific
monoclonal antibody (data not shown). Immunoprecipitated
HA-SEK immobilized on protein A-Sepharose was assayed for
its ability to phosphorylate bacterially expressed GST-SAPK in
vitro. As shown in Fig. 4, HA-SEK was activated by MMS
within 2 h. To investigate the involvement of MEKK1 in the
MMS response, transfection experiments were performed in
the presence or absence of an expression vector encoding a
transdominant-negative mutant of MEKK1 (51). The activa-
tion of SEK1 by MMS could be blocked by overexpression of
the transdominant-negative mutant, suggesting that MEKK1,
or a closely related kinase, is also part of the signal transduc-
tion pathway induced by MMS.
The MMS response is independent of a nuclear signal. Hav-
ing identified p38, JNK/SAPKs, SEK1, and MEKK1 (or a close-
ly related protein kinase) as being activated by MMS, we want-
ed to determine the primary cellular targets.
The experiments described above showed that the specific
initiation of the stress-activated signal transduction pathway
leading to activation of JNK/SAPK and p38 MAPK clearly
depends on the electrophilic reactivity of the alkylating agents
and, thereby, the affected alkylation products, either nucleic
acids, lipids, or proteins. Most recently, DNA damage has been
suggested to be the initiating signal in response to cis-platinum
and mitomycin in activating signal transduction pathways that
include activation of c-Abl and JNK/SAPKs (39). However, in
agreement with recent findings (45), mitomycin activated c-Abl
but not JNK/SAPKs, whereas MMS was a very poor inducer of
c-Abl but efficiently activated JNK/SAPK activity (data not
shown). On the other hand, induction of JNK/SAPKs by UV
irradiation has been found to be independent of DNA damage
(26). To determine whether modification of DNA and/or other
cellular components are essential intermediates of the cellular
response against alkylating agents, such as MMS and MNNG,
we first investigated the requirement of nuclear signals gener-
ated by alkylation of genomic DNA in activation of the JNK/
SAPK pathway.
To directly analyze the possible role of alkylation of the
nuclear DNA in the activation of the JNK/SAPK cascade, we
measured JNK/SAPK activity in cells lacking nuclei (cyto-
plasts). Mouse L cells were enucleated by centrifugation in the
presence of cytochalasin B, and the efficiency of enucleation
was estimated by staining intact cells and cytoplasts with a
fluorescent dye for nuclear DNA. As shown in Fig. 5A, almost
100% of the cells were enucleated. The JNK/SAPK activity in
intact cells and cytoplasts, which were left untreated or treated
with MMS, was determined by an immune complex kinase
assay. As described previously (26), we usually observed an
increase in basal JNK/SAPK activity in cytoplasts, compared to
intact cells, possibly due to the cytochalasin B treatment. Nev-
ertheless, in three independent experiments treatment with
MMS always induced JNK/SAPK activation in cells lacking
their nuclei with an activation factor (4.3-fold) similar to that in
intact cells (4.8-fold) (Fig. 5B). In agreement with previous
findings (26), under these conditions we also observed JNK/
SAPK activation by UV irradiation in cytoplasts (data not
shown).
These experiments rule out the absolute requirement of a
nuclear signal generated by alkylation of genomic DNA for
induction of JNK/SAPK activity by MMS. Although we have
not eliminated the possibility that mitochondria are involved in
JNK/SAPK activation, as suggested for heat shock-dependent
JNK/SAPK activation (1), we favor the concept that, as for UV
(1), the primary signal induced by MMS that initiates the
JNK/SAPK signal transduction pathway is established in the
cytoplasm or cell membrane.
The MMS response does not involve cell surface receptors.
Having excluded genomic DNA as a prerequisite for the MMS
response, we wanted to know if the primary signal is initiated
at the cell membrane and whether it involves cell surface re-
ceptors. Candidate receptors which are possibly affected by
MMS are those for interleukin-1, TNF-a, EGF, and G-protein-
coupled receptors, which have been found to be involved in
common routes of signal transduction pathways leading to
JNK/SAPK activation (42, 51, 65, 72, 80).
Examples of G-protein-coupled receptors which are primary
targets for initiation of JNK/SAPK-specific pathways are the
m1 and m2 muscarinic receptors (16, 17). Activation of this
pathway involves bg subunits of heterotrimeric G proteins.
This activation can be nearly abolished by expression of b-ad-
renergic receptor kinase (bARK), which sequesters free bg
complexes when dissociated from Ga subunits upon receptor
stimulation, thus blocking bg-dependent pathways (18).
To analyze whether MMS induces the cellular response by
mimicking activation of G-protein-coupled receptors, we de-
termined the involvement of bg subunits of heterotrimeric G
proteins in the MMS response in mouse L cells which were
stably expressing the bARK. For activation of a G-protein-
coupled receptor, we used lysophosphatidic acid (LPA), an
albumin-bound phospholipid mitogen that is released from
activated platelets (for reviews, see references 36, 54, and 55).
Treatment of the parental cell line with LPA activated JNK/
SAPKs within 15 min, and this activation was nearly abolished
in the stably transfected clones expressing the transdominant
negatively acting bARK protein. In contrast, JNK/SAPK ac-
tivity induced by MMS, UV, and TNF-a was even slightly
enhanced in the stably transformed cells compared to their
wild-type counterparts (Fig. 6). These experiments rule out
that MMS activates JNK/SAPKs via bg subunits of heterotri-
meric G proteins, at least in L cells.
It has been shown for UV irradiation that among the pri-
mary targets are growth factor receptors, such as the EGF
receptor (66). The direct involvement of growth factor recep-
tors in UV-induced signalling was demonstrated by exploiting
the effects of suramin, which is a general inhibitor of the
function of membrane-positioned receptors (9, 35, 83). To
address the question of whether MMS and UV irradiation
have the same primary target, activation of growth factor re-
ceptors, we determined activation of JNK/SAPKs by UV irra-
diation and MMS treatment in the presence or absence of
suramin. Cells were pretreated with suramin prior to induction
with MMS or UV irradiation, and JNK/SAPK activity was
FIG. 4. MEKK-dependent activation of SEK by MMS. Human 293 cells were
cotransfected with an expression vector encoding HA-tagged SEK together with
an empty expression vector (2) or a vector encoding transdominant-negative
MEKK (1 DMEKK). The cells were not treated (Co) or treated with MMS (1
mM), and whole-cell extracts were prepared 2 h poststimulation. Exogenously
expressed SEK was immunoprecipitated with the HA-specific monoclonal anti-
body, and the kinase activity was measured by immune complex assay using
[g-32P]ATP and GST-SAPK as substrates. The products of the phosphorylation
reaction were resolved by SDS-PAGE and detected by autoradiography.
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determined by an in-gel kinase assay. The data are clear-cut:
activation of JNK/SAPKs by UV irradiation was markedly re-
duced by pretreatment of cells with suramin, whereas the in-
duction by MMS was not affected. Suramin alone had no effect
on JNK/SAPK activity (Fig. 7). This result shows that although
MMS and UV irradiation activate common routes of signal
transduction pathways, they differ in their primary targets.
Inhibition of the MMS response by GSH and NAC. Al-
though the primary target of MMS is still unknown, modula-
tion of poly(ADP-ribose) polymerase may be important for
MMS-induced signalling. Activation of this enzyme, which is a
component of the cellular DNA repair machinery, has meta-
bolic consequences, particularly the consumption of NAD re-
sulting in a depletion of ATP. An inhibitor of poly(ADP-
ribose) polymerase, 3-aminobenzamide (ABA), prevented the
depletion of NAD and ATP and the subsequent cell killing by
MMS (53). On the other hand, there is evidence that the
intracellular level of GSH, regulating the redox state of the cell
(for a review, see reference 49), may be an important sensor
for the initiation of the cellular response to alkylating agents.
GSH and thiols play a crucial role in the detoxification of
oxidative stress by carcinogenic xenobiotics (15), and an ele-
vated level of GSH has been associated with acquired alkylat-
ing resistance (10).
To assess the role of oxidative stress and poly(ADP-ribosyl)
ation in the activation of JNK/SAPKs and p38 by MMS, we
studied the effects of pretreatments of cells with GSH, NAC,
and ABA prior to MMS induction in mouse fibroblasts, in
Jurkat cells, and in 293 cells. In all three cell lines, activation of
JNK/SAPKs, measured by an immune complex kinase assay,
was found to be inhibited by both GSH and NAC pretreat-
ment, whereas the poly(ADP-ribose) polymerase inhibitor
ABA had no effect (Fig. 8 and data not shown). Similarly,
activation of p38 by MMS was blocked in the presence of GSH
(data not shown). GSH and NAC alone did not affect the
activation status of JNK/SAPKs or p38 in a time period of up
to 4 h (data not shown).
To obtain additional support for a critical role of GSH in the
JNK/SAPK activation by MMS, the cellular GSH pool was
depleted by treatment of the cells with BSO. BSO is a specific
inhibitor of g-glutamylcysteine synthetase, the enzyme respon-
sible for the first and rate-limiting step of GSH synthesis (50).
Immune complex kinase assays revealed that treatment of the
cells with 500 mM BSO alone did not induce JNK/SAPK ac-
tivity (data not shown). Induction of JNK/SAPKs with subop-
timal doses of MMS (500 mM [Fig. 9]; see also Fig. 1) was
dramatically enhanced by pretreatment with BSO.
These results demonstrate that the cellular GSH content is
a critical parameter for the stress signaling cascade induced by
MMS. To test if the inhibition of JNK/SAPK activity by GSH
and NAC is specific for induction by alkylating agents, we
investigated the effect of pretreatment of 293 cells with GSH
and NAC on the JNK/SAPK activation by UV irradiation or
treatment with TNF-a. In agreement with previous findings (1,
FIG. 5. Activation of JNK/SAPKs in cytoplasts. Mouse L cells were left untreated or treated with cytochalasin B (10 mg/ml) and left intact or enucleated by
centrifugation. (A) Cytoplasts and intact cells were stained with the fluorescent DNA dye Hoechst 33528 (lower panel). (B) Adherent cytoplasts and intact cells were
either left untreated (Co) or exposed to MMS (1 mM). After 2 h, cells and cytoplasts were harvested, and total cell extracts were prepared. JNK/SAPKs were
immunoprecipitated with rabbit polyclonal antibodies, and the protein kinase activity was measured in the immune complex with GST-Jun and [g-32P]ATP as substrates.
The products of the phosphorylation reaction were resolved by SDS-PAGE and detected by autoradiography.
FIG. 6. The MMS response does not include activation of G-protein-coupled
receptors. Wild-type mouse L cells (2) and stably transformed derivatives ex-
pressing bARK (1) were left untreated (Co), treated with MMS (1 mM, 2 h),
TNF-a (5 ng/ml, 15 min), or LPA (10 mg/ml, 15 min), or irradiated with UV (40
J/m2, 30 min), and whole-cell extracts were prepared. JNK/SAPKs were immu-
noprecipitated with rabbit polyclonal antibodies, and the protein kinase activity
was measured in the immune complex with GST-Jun and [g-32P]ATP as sub-
strates. The products of the phosphorylation reaction were resolved by SDS-
PAGE and detected by autoradiography.
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25), both GSH or NAC are potent inhibitors of UV-mediated
JNK/SAPK activation (Fig. 10 and data not shown), whereas
activation by TNF-a is not impaired (Fig. 10), suggesting the
existence of specific cellular components involved in the JNK/
SAPK activation in response to different forms of cellular
stress.
DISCUSSION
Monofunctional alkylating agents like MMS and MNNG
induce a specific program of gene expression, known as the
cellular stress response, which is commonly activated by a
variety of environmental cues, such as chemical carcinogens
and UV irradiation. This program includes the activation of
JNK/SAPK activity required for transcriptional activation of
c-fos and c-jun, whose gene products have been proposed to be
required for the cellular defense against genotoxic agents such
as UV (68).
To understand the primary reactions of the cell in response
to alkylating agents, the mechanisms responsible for the acti-
vation of stress-related protein kinases need to be identified.
Here we show that MMS and MNNG, like other cellular
stress-inducing agents, such as UV irradiation, heat shock, and
protein synthesis inhibitors, activate both the JNK/SAPKs and
another member of the MAPK family, the HOG1 homolog p38
MAPK. This activation was independent of the cytotoxic prop-
erties of MMS: even at a concentration of MMS (10 mM) that
does not affect cell viability (40b), JNK/SAPK activity was
significantly induced. Moreover, ABA, an inhibitor of poly-
(ADP-ribose) polymerase which prevents depletion of NAD
and ATP and the subsequent killing by alkylating agents (53),
had no effect on the activation of JNK/SAPK by MMS.
The activity of the third subgroup of MAP kinases, consist-
ing of ERK-1 and ERK-2, is not affected by MMS. This specific
activation of different subfamilies of MAPKs reveals the exis-
tence of parallel MAPK cascades that can be activated inde-
pendently and simultaneously, representing a common mech-
anism of signal transduction that has been adapted to couple
different stimuli to distinct physiological responses.
Despite the slower kinetics of induction of JNK/SAPKs and
p38 by MMS and MNNG (compared to UV), reaching maxi-
mal levels between 1 and 2 h poststimulation, efficient induc-
tion of JNK/SAPK activity in enucleated cells (cytoplasts)
strongly suggests a direct activation of protein kinase and/or
inhibition of active phosphatase cascades which does not re-
quire MMS-induced transcriptional activation of cellular genes
and enhanced de novo protein synthesis. Recently, members of
protein kinase cascades induced by extracellular stimuli such as
UV and TNF-a have been identified. By transient transfection
assays, under conditions where UV-induced activation of SEK
was not yet detectable, we observed enhanced kinase activity of
an epitope-tagged SEK1, also known as MKK4 or JNKK, in
response to MMS, which could be blocked by overexpression
of a transdominant negative form of MEKK1. MEKK1 has
been reported to function preferentially in the JNK/SAPK
pathway, specifically controlling SEK1/MKK4 activity (51, 82),
but not MKK3, the direct upstream activator of p38 MAPK
(23). Since p38 MAPK is also activated by MMS, the inhibition
by the transdominant negative MEKK1 protein may be ex-
plained by the existence of a closely related protein kinase
which shares the binding sequence and phosphorylation motif
for their upstream protein kinase. This MEKK1-related kinase
may phosphorylate and thereby activate MKK3. The existence
of MEKK1-related protein kinases critical for the MMS re-
sponse is also supported by our findings that the transactiva-
tion of JNK/SAPKs by MEKK1 cannot be further enhanced by
MMS treatment (data not shown). Interestingly, the activation
of these pathways does not represent a general cellular re-
sponse to different classes of alkylating agents. MMS and
MNNG, which show similar reaction kinetics and similar af-
finities to nucleophilic sites, are very potent activators of JNK/
SAPK activity. In contrast, ENU, which acts by a different
reaction mechanism (SN1 instead of SN2), and thereby prefer-
entially attacks other nucleophilic sites leading to different
alkylation products, was unable to activate JNK/SAPK activity.
The differences in the adducts are well defined with respect to
the alkylation of DNA. Nevertheless, we provide evidence that
FIG. 7. The MMS response does not involve growth factor receptors. Cell
extracts from untreated human 293 cells (Co) or from cells treated with MMS (1
mM, 2 h) or irradiated with UV (40 J/m2, 30 min), either without (2) or with (1)
pretreatment with suramin (0.3 mM, 40 min), were subjected to an in-gel kinase
assay using GST-Jun as the substrate.
FIG. 8. Inhibition of the MMS response by GSH and NAC. Human 293 cells
were left untreated (Co) or treated for 2 h with GSH (15 mM), ABA (10 mM),
or NAC (15 mM) and cultured in the presence or absence of MMS (1 mM, 2 h).
Whole-cell extracts were prepared, and JNK/SAPKs were immunoprecipitated.
The protein kinase activity was measured in the immune complex, using GST-
Jun and [g-32P]ATP as substrates. The products of the phosphorylation reaction
were resolved by SDS-PAGE and detected by autoradiography.
FIG. 9. Depletion of endogenous GSH leads to superinduction of JNK/
SAPKs by MMS. Human 293 cells were left untreated (2) or treated with 1 mM
BSO for 24 h, followed by treatment with MMS (500 mM). Whole-cell extracts
were prepared at the indicated times after addition of MMS, and JNK/SAPKs
were immunoprecipitated. The protein kinase activity was measured in the im-
mune complex, using GST-Jun and [g-32P]ATP as substrates. The products of
the phosphorylation reaction were resolved by SDS-PAGE and detected by
autoradiography.
FIG. 10. GSH and NAC inhibit JNK/SAPK activation by MMS and UV but
not by TNF-a. Human 293 cells were left untreated (Co) or treated with GSH
(15 mM) or NAC (15 mM). Subsequently, cells were left untreated, treated with
MMS (1 mM, 2 h) or TNF-a (5 ng/ml, 15 min), or irradiated with UV (40 J/m2,
30 min). Whole-cell extracts were prepared at the indicated time points, and
JNK/SAPKs were immunoprecipitated. The protein kinase activity was measured
in the immune complex, using GST-Jun and [g-32P]ATP as substrates. The
products of the phosphorylation reaction were resolved by SDS-PAGE and
detected by autoradiography.
VOL. 17, 1997 REDOX-DEPENDENT SIGNALLING BY ALKYLATING AGENTS 4797
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
alkylation of genomic DNA is not critical for induction of the
MMS response. Most importantly, by preparing cytoplasts, we
found that induction of JNK/SAPK activity by MMS did not
require alkylation of nuclear DNA. In addition, c-Abl, a non-
receptor tyrosine kinase which has been suggested to be acti-
vated selectively by DNA-damaging agents (ionizing radiation,
mitomycin, and cis-platinum) and whose activation correlates
with the activation of JNK/SAPKs (39), seems not to be in-
volved in the MMS response (reference 45 and data not
shown). Although we cannot completely rule out the involve-
ment of alkylation of mitochondrial DNA, taken together,
these data favor the concept that specific alkylation of compo-
nents in the cytoplasm or cell membrane by MMS and MNNG,
but not ENU, triggers the initiation of signal transduction
pathways involving JNK/SAPKs and p38.
Although MMS and UV irradiation share common routes of
signal transduction pathways, such as activation of JNK/SAPK
and p38 activity, hyperphosphorylation of c-Jun and ATF-2,
and transcriptional activation of c-jun and c-fos expression, the
primary cellular targets of UV and MMS are clearly different.
Among the targets of UV are cell surface receptors in the cell
membrane, which are activated immediately after irradiation
of the cells and can be blocked by pretreatment of the cells
with the inhibitor suramin (66). In agreement with these find-
ings, we observed an efficient reduction of JNK/SAPK activa-
tion in response to UV. In contrast, we did not find an effect of
suramin on the activation of JNK/SAPK activity by MMS. In
line with these findings, we did not obtain evidence for MMS-
induced hyperphosphorylation of the EGF receptor (40a),
which is a characteristic of UV-induced immediate-early
events (66). The involvement of membrane-associated recep-
tors in the UV response was also supported by the reduction of
UV-induced activation of JNK/SAPKs in the presence of low
concentrations of Triton X-100 (1). In contrast, Triton X-100
treatment did not affect MMS-induced JNK/SAPK activation
(81a). In addition to the resistance of the MMS response to
suramin, we were able to rule out the involvement of bg sub-
units of heterotrimeric G proteins coupled to cell surface re-
ceptors in the MMS response, at least in L cells. Stimulation of
such G-protein-coupled receptors, e.g., m1 and m2 muscarinic
receptors, was found to activate JNK/SAPKs through the bg
subunit of heterotrimeric G proteins (16, 17). Here we show
that LPA, recently emerging as an intercellular phospholipid
messenger with a wide range of biological activities (for re-
views, see references 54 and 55), can activate the JNK/SAPK
pathway. This activation is mediated by the bg subunit of the
heterotrimeric G protein activated by its specific receptor. Ac-
cordingly, induction could be blocked by overexpression of a
CD8-bARK chimeric protein which sequesters free bg com-
plexes when dissociated from Ga subunits (18). In contrast,
activation of JNK/SAPK activity by MMS was unaffected by
the CD8-bARK fusion protein.
Despite exclusion of many components of signal transduc-
tion pathways induced by other types of cellular stress-inducing
agents, the primary target molecule(s) responsible for initia-
tion of MMS-specific signal transduction remains to be iden-
tified. Possibly, MMS directly methylates one or multiple up-
stream components of signal transduction pathways, e.g.,
MEKK1, PAKs, Cdc42, Rho, and/or Rac1 (16, 17, 51, 52, 67,
79, 82), and thereby activates these proteins by changing their
conformation. In fact, overexpression of a transdominant neg-
ative mutant of Rac1, but not Rho, reduced MMS-dependent
induction of JNK/SAPK activity (45). Since ENU, in contrast
to MMS and MNNG, does not activate the JNK/SAPK path-
way, the specific modifications of these critical proteins created
by MMS and MNNG and by ENU must be different. Although
protein modifications induced by monofunctional alkylating
agents have not been analyzed in great detail, qualitative and
quantitative differences have been observed in vitro (61). It is
also possible that MMS inhibits a specific phosphatase respon-
sible for downregulation of one, or multiple, activated up-
stream protein kinases. Inhibition of a constitutive dual-spec-
ificity JNK phosphatase has been found to be responsible for
JNK/SAPK and p38 activation by arsenite (14). Because MMS
leads to induction of the JNK/SAPK kinase SEK1, which can
be inhibited by a transdominant-negative mutant of MEKK,
inactivation of JNK phosphatase cannot account for JNK/
SAPK activation in response to MMS. A similar scenario of
phosphatase-dependent activation of signal transduction path-
ways has been established recently for the activation of the
EGF and platelet-derived growth factor receptors by UV (40).
Inhibition of a protein tyrosine phosphatase by UV is due to
direct modification of catalytically important SH groups of
tyrosine phosphatases which can be blocked in the presence of
reducing agents, such as NAC (40). This is in agreement with
previous findings demonstrating that oxidative stress contrib-
utes in part to the transient JNK/SAPK activation and induc-
tion of c-jun transcription by UV (1, 14, 25). In contrast to UV,
we did not obtain evidence for direct modification of SH
groups of tyrosine phosphatases by MMS (40a). In fact, in vitro
MMS preferentially modifies lysine and histidine residues,
rather than cysteines (60). Nevertheless, we found the redox
state of the cell very critical for induction of the MMS re-
sponse. JNK/SAPK activation by MMS is inhibited by pretreat-
ment of the cells with GSH or NAC, which acts by raising the
intracellular concentrations of cysteine and hence of GSH (5).
Vice versa, depletion of the intracellular pool of GSH resulted
in superinduction of JNK/SAPK activity. GSH and other thiols
play a crucial role in the detoxification of carcinogenic xeno-
biotics (15). Although GSH and NAC interfere with both UV-
and MMS-induced signalling, the mechanisms of interference
are different. While the direct modification of SH groups of
growth factor receptor tyrosine phosphatases by UV leading to
inactivation is blocked by NAC, the lack of EGF receptor
phosphorylation by MMS and the resistance of MMS-induced
JNK/SAPK activation against suramin and Triton X-100 strong-
ly suggest that the targets of GSH and NAC interference in
UV- and MMS-induced signalling are different. It has been
shown that GSH can directly react with alkyl methanosulfon-
ates, probably via GST-mediated catalysis (41). Accordingly,
both MMS and MNNG cause a rapid decrease in cellular GSH
(53). This manipulation of the cellular GSH content may be
the trigger for induction of oxidative stress which causes, via a
yet unknown sensor, the activation of JNK/SAPKs. However,
neither depletion of GSH by treatment with BSO nor treat-
ment of cells with GSH or NAC activated JNK/SAPKs. Thus,
it is likely that GSH and NAC, by interacting directly or
through enzyme-catalyzed reactions with electrophilic com-
pounds, resemble a dominating competitive pathway reducing
the number of reactions of alkylating agents with critical target
molecules.
Regardless of the primary receptor for MMS and MNNG,
these agents activate JNK/SAPK- and p38-specific signal trans-
duction pathways, resulting in hyperphosphorylation of c-Jun,
ATF-2, and TCF/Elk (12, 13, 65, 78, 81, 84). In turn, c-jun and
c-fos transcription is induced, leading to newly synthesized
c-Jun and c-Fos proteins, the major components of transcrip-
tionally active AP-1. AP-1 has been found to bind DNA-reg-
ulatory elements in the promoters of several xenobiotic-me-
tabolizing enzymes: GSTs, glucuronyltransferases, and NAD
(P)H:quinone reductase (8). Transcriptional activation of these
genes leads to an enhanced GSH level in the cells within 4 h
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(47). This rise in GST content may allow inactivation of MMS
and may therefore be responsible, at least in part, for down-
regulation of JNK/SAPK activity 4 to 6 h poststimulation. Our
data suggest that induction of JNK/SAPKs and p38 may be an
important mechanism for controlling the genetic program
which cells use to actively and immediately respond to envi-
ronmental cues by induction of proteins that are ultimately
responsible for detoxification of cytotoxic xenobiotics.
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